Literature DB >> 3232536

Fat consumption and schizophrenia.

O Christensen1, E Christensen.   

Abstract

This report describes the statistical association between the average ratings of course and outcome of schizophrenia in 8 national centres participating in the World Health Organization international 2-year follow-up study (1) and the amount of fat in the average national diets as published by the Food and Agriculture Organization of the United Nations (2). Highly significant correlations were found between favourable ratings of course and outcome of schizophrenia and a low percentage of total fat (r = 0.80-0.90; P less than 0.05) and of fat from land animals and birds (composed mainly of saturated fat) (r = 0.91-0.95; P less than 0.01). High percentage of fat from vegetables, fish and seafood (having a relatively high content of unsaturated fatty acids) tended to be associated with a favourable course and outcome (r = 0.23-0.50; P greater than 0.10). A multivariate analysis revealed that 97% (P = 0.0002) of the variation in the overall outcome of schizophrenia between the national centres could be explained by the combined variation in the percentages of fat from land animals and birds and from vegetables, fish and seafood, respectively, in the national diets. These results suggest that the course and outcome of schizophrenia may be influenced through diet. They should encourage investigators to perform controlled clinical trials of low-fat diets with a sufficient amount of essential fatty acids.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3232536     DOI: 10.1111/j.1600-0447.1988.tb06388.x

Source DB:  PubMed          Journal:  Acta Psychiatr Scand        ISSN: 0001-690X            Impact factor:   6.392


  18 in total

1.  Oil and water or oil and vinegar? Evidence-based medicine meets recovery.

Authors:  Larry Davidson; Robert E Drake; Timothy Schmutte; Thomas Dinzeo; Raquel Andres-Hyman
Journal:  Community Ment Health J       Date:  2009-08-02

2.  Fatty acids and schizophrenia.

Authors:  J D Laugharne; J E Mellor; M Peet
Journal:  Lipids       Date:  1996-03       Impact factor: 1.880

Review 3.  Oxidative damage and schizophrenia: an overview of the evidence and its therapeutic implications.

Authors:  J K Yao; R D Reddy; D P van Kammen
Journal:  CNS Drugs       Date:  2001       Impact factor: 5.749

Review 4.  Omega-3 fatty acids in the treatment of psychiatric disorders.

Authors:  Malcolm Peet; Caroline Stokes
Journal:  Drugs       Date:  2005       Impact factor: 9.546

Review 5.  Polyunsaturated fatty acid supplementation for schizophrenia.

Authors:  C B Joy; R Mumby-Croft; L A Joy
Journal:  Cochrane Database Syst Rev       Date:  2006-07-19

Review 6.  Clinical potential of omega-3 fatty acids in the treatment of schizophrenia.

Authors:  Robin Emsley; Piet Oosthuizen; Susan J van Rensburg
Journal:  CNS Drugs       Date:  2003       Impact factor: 5.749

7.  Dietary intake of fish, omega-3, omega-6 polyunsaturated fatty acids and vitamin D and the prevalence of psychotic-like symptoms in a cohort of 33,000 women from the general population.

Authors:  Maria Hedelin; Marie Löf; Marita Olsson; Tommy Lewander; Björn Nilsson; Christina M Hultman; Elisabete Weiderpass
Journal:  BMC Psychiatry       Date:  2010-05-26       Impact factor: 3.630

8.  Relation of schizophrenia prevalence to latitude, climate, fish consumption, infant mortality, and skin color: a role for prenatal vitamin d deficiency and infections?

Authors:  Dennis K Kinney; Pamela Teixeira; Diane Hsu; Siena C Napoleon; David J Crowley; Andrea Miller; William Hyman; Emerald Huang
Journal:  Schizophr Bull       Date:  2009-04-08       Impact factor: 9.306

9.  Changes in erythrocyte membrane fatty acids during a clinical trial of eicosapentaenoic acid (EPA) supplementation in schizophrenia.

Authors:  Susan J van Rensburg; Cornelius M Smuts; Dinie Hon; Martin Kidd; Sulene van der Merwe; Christo Myburgh; Piet Oosthuizen; Robin Emsley
Journal:  Metab Brain Dis       Date:  2009-10-14       Impact factor: 3.584

10.  Cross-national differences in the frequency and outcome of schizophrenia: a comparison of five hypotheses.

Authors:  S Gupta
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  1992-10       Impact factor: 4.328

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.